FindMyKOL
Clinical trialNCT02171312CompletedObservational

Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool

NCT02171312 is an observational study sponsored by Emory University. As of 21 Nov 2026, it is completed. It studies Mild Concussion, Post Concussion Syndrome and 1 more condition. The registry lists an enrollment of 126 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2015 and a primary completion date of 30 Sept 2015.

SponsorEmory University →Enrollment126Mild ConcussionPost Concussion SyndromeVestibular Neuritis
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02171312
FieldValue
Registry IDNCT02171312
StatusCompleted
Study typeObservational study
Lead sponsorEmory University
Enrollment126
Registered sites1
Countries1
ConditionsMild Concussion, Post Concussion Syndrome and Vestibular Neuritis
Start30 Apr 2015
Primary completion30 Sept 2015
Study completion30 Sept 2015
Last update posted9 Feb 2016

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The iDETECT (Integrated Display Enhanced Testing for Concussion and mild traumatic brain injury) system is a novel portable, open access platform that enables immediate and rapid assessment of multimodal neurologic function. This study seeks to evaluate the iDETECT function testing battery with currently used balance and inner ear assessment methods during initial concussion clinic referral. Two groups of participants will be enrolled; a concussion related dizziness cohort and control subjects. The investigators will enroll the concussion cohort from patients presenting to the Sports Concussion Institute (SCI) with persistent dizziness and imbalance symptoms following possible concussion. Healthy control participants will be recruited from the local community. iDETECT's ability to identify post concussion balance/vestibular disturbances will be compared to an expert concussion assessment. Both cohorts will participate in the iDETECT assessment and the clinical assessment.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Georgia, United States1 site
  • Sports Concussion Institute

    Atlanta

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgia: 1 siteGA1HawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02171312

Each answer restates registry values shown on this page.

What is NCT02171312?

NCT02171312 is an observational study sponsored by Emory University. It studies Mild Concussion, Post Concussion Syndrome and 1 more condition.

Who leads NCT02171312?

The registry names David W Wright, MD (principal investigator, Emory University) and Russell Gore, MD (principal investigator, Sports Concussion Institute) as overall officials.

Where does NCT02171312 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT02171312 end?

The registry lists a primary completion date of 30 Sept 2015 and a study completion date of 30 Sept 2015. The sponsor last updated the record on 9 Feb 2016.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.